Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
60 /100
HIGH RISK
Score updated Aug 28, 2026

GOSS — Gossamer Bio, Inc. Dilution Risk Tracker

Track GOSS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GOSS — Get alerts when the score changes →

As of August 28, 2026, Gossamer Bio, Inc. (GOSS) has a DilutionWatch DilutionScore of 60/100, rated HIGH dilution risk. Gossamer Bio, Inc. has a market capitalization of $54.19M, 488.85M shares outstanding, 193 institutional holders tracked. Stored dilution-related fields include 32.47M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
85
📊 Float Risk
52
⚠️ Warrant Exposure
30
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 48%
🔄 Reverse Split model est. 70%
• 50-day avg $0.34 below $1 exchange minimum
• Only 4 months cash — financial pressure
💰 Capital Raise model 35%
• Low cash runway: 4 months remaining
📜 Warrant Exercise model 15%
• Warrant overhang: 6.6% of shares outstanding
🔔 Track GOSS — Get forecast alerts →

Market Data

Market Cap$54.19M
Shares Outstanding488.85M
Float227.18M
Cash$57.03M
Debt$11.61M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 3.1% shares (2026Q1 vs prior)
193 institutional holders · 203.27M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 18.79M shares
#2 Kalehua Capital Management LLC 17.71M shares
#3 BlackRock, Inc. 16.83M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest94.99M
Days to Cover1.5
% of Float41.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
xbrl XBRL CONVERTIBLE 2022-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual GOSS Dilution Snapshot

Gossamer Bio, Inc. (GOSS) has a DilutionScore of 60/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track GOSS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GOSS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GOSS
GOSS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.